Position
ALLIANCEBERNSTEIN L.P. in Vaxcyte, Inc.
Back to the book · All holders of PCVX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $0$46.14 → $46.14
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 133.9K | $6.18M | — | — | — | 0.0% |
| Q1 2026 | 137.1K | $6.32M | $46.14 | $0 | $147.6K | 0.0% |